Bristol-Myers Squibb selects Mass General exec as chief scientific officer: 4 things to know

New York City-based Bristol-Myers Squibb Company appointed Thomas J. Lynch, Jr., MD, executive vice president and chief scientific officer, effective March 16, 2017.

Advertisement

Here are four things to know:

1. Dr. Lynch served as chairman and CEO of Boston-based Massachusetts General Physicians Organization since July 2015.

2. He also serves on Bristol-Myers Squibb’s board of directors, but he will step down, effective March 15, 2017.

3. Previously, he served as director of New Haven, Conn.-based Yale Cancer Center and was the Richard and Jonathan Sackler Professor of Internal Medicine at the Yale School of Medicine.

4. He succeeds Francis Cuss, MD, who is retiring.

More articles on executive moves:
Heath Evans is South Georgia Medical Center’s interim CEO: 4 points
PinnacleHealth names Philip Guarneschelli CEO: 5 notes
Methodist Hospital CEO Gary Colberg resigns 11 months into tenure

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.